在制药制造业推进安全和可持续的设计实践:PHARMECO项目
Sándor B Ötvös1,2, Bert Verstappen3, Bruno Baillon4
1Center for Continuous Flow Synthesis and Processing (CCFLOW), Research Center Pharmaceutical Engineering GmbH (RCPE), Inffeldgasse 13, A-8010, Graz, Austria.
ChemSusChem
|October 10, 2025
概括
PHARMECO是一个欧洲倡议,通过可持续技术改变制药制造业. 该项目旨在减少环境影响,同时确保医疗保健的质量和患者安全.
科学领域:
- 制药制造业 制药制造业 制药制造业
- 可持续技术 可持续技术
- 环境科学 环境科学
背景情况:
- 欧洲公私合作伙伴关系PHARMECO于2024年11月启动,旨在解决制药制造业可持续转型的需要.
- 该倡议涉及主要的制药和医疗技术公司,学术机构,研究机构,中小企业和政府机构.
- 这是一个为期六年的多学科项目,由欧盟,创新健康倡议联合企业 (IHI JU) 和英国研究与创新 (UKRI) 共同资助.
研究的目的:
- 通过推进可持续技术,推动制药制造业的转型.
- 为了减少制药行业的环境足迹,而不影响产品质量或患者安全.
- 概述PHARMECO的愿景,结构,关键方法以及对欧洲可持续医疗保健的预期影响.
主要方法:
- 在制药制造业中加强生产过程.
- 制定协调的方法来评估制造工艺的可持续性.
- 促进多学科努力,涉及来自行业,学术界和政府的各种利益相关者.
主要成果:
- 该项目重点是推进可持续技术,减少制药生产对环境的影响.
- 目前正在开发协调的可持续性评估方法.
- 该倡议旨在为整个欧洲的可持续医疗保健提供长期贡献.
结论:
- 法美科准备为欧洲更可持续的制药制造业做出重大贡献.
- 该项目的多学科方法和重点是创新,预计将带来巨大的环境和医疗保健效益.
- 这一举措是将可持续性纳入制药生产核心的关键一步.
更多相关视频
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
4.4K
07:48A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
22.7K
相关概念视频
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
233
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
233
01:26FDA Approved Drugs: Changes to Approved Drugs
242
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
242
01:28Biopharmaceutics and Pharmacokinetics: Overview
3.3K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.3K
01:28Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
01:26Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
203
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
203